Aller au contenu principal
Accès ouvert déclaré 2023 review

Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review

31Citations signalées — pas une note de qualité
160Institutions déclarées
26Pays d’affiliation déclarés

Résumé fourni par la source

BACKGROUND: The greatest change in the treatment of people living with type 1 diabetes in the last decade has been the explosion of technology assisting in all aspects of diabetes therapy, from glucose monitoring to insulin delivery and decision making. As such, the aim of our systematic review was to assess the utility of these technologies as well as identify any precision medicine-directed findings to personalize care. METHODS: Screening of 835 peer-reviewed articles was followed by systematic review of 70 of them (focusing on randomized trials and extension studies with ≥50 participants from the past 10 years). RESULTS: We find that novel technologies, ranging from continuous glucose monitoring systems, insulin pumps and decision support tools to the most advanced hybrid closed loop systems, improve important measures like HbA1c, time in range, and glycemic variability, while reducing hypoglycemia risk. Several studies included person-reported outcomes, allowing assessment of the burden or benefit of the technology in the lives of those with type 1 diabetes, demonstrating positive results or, at a minimum, no increase in self-care burden compared with standard care. Important limitations of the trials to date are their small size, the scarcity of pre-planned or powered analyses in sub-populations such as children, racial/ethnic minorities, people with advanced complications, and variations in baseline glycemic levels. In addition, confounders including education with device initiation, concomitant behavioral modifications, and frequent contact with the healthcare team are rarely described in enough detail to assess their impact. CONCLUSIONS: Our review highlights the potential of technology in the treatment of people living with type 1 diabetes and provides suggestions for optimization of outcomes and areas of further study for precision medicine-directed technology use in type 1 diabetes.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
Date Crossref
05/10/2023
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

University of FloridaYale UniversityBaylor College of MedicineTexas Children's HospitalChildren's Nutrition Research Center at Baylor College of MedicineStanford UniversityUniversity of Colorado DenverUniversity of WashingtonTranslational Research Institute for Metabolism and DiabetesJoslin Diabetes CenterHarvard UniversityKU LeuvenBrigham and Women's HospitalUniversity of CopenhagenNovo Nordisk FoundationMassachusetts General HospitalLund UniversityUniversity of CambridgeRosie HospitalUniversity of CalgaryMadras Diabetes Research FoundationCardinal Glennon Children’s Medical CenterSaint Louis UniversityUniversity of ExeterUniversitat Autònoma de BarcelonaInstituto de Salud Carlos IIIHospital de Sant PauBiomedical Research Networking Center in Bioengineering, Biomaterials and NanomedicineInstitut de Recerca Sant PauBroad InstituteJohns Hopkins UniversityJohns Hopkins MedicineIndiana University School of MedicineIndiana University – Purdue University IndianapolisRutgers, The State University of New JerseyCentre Hospitalier Universitaire Sainte-JustineUniversité de MontréalErasmus MCUniversity of DundeeGenomics (United Kingdom)University of North Carolina at Chapel HillUniversity of HelsinkiHelsinki University HospitalInstitute for Molecular Medicine FinlandFolkhälsans ForskningscentrumBoston Children's HospitalChinese University of Hong KongUniversity of MalayaAsia Diabetes FoundationBoston Children's MuseumUniversity of Eastern FinlandKuopio University HospitalThe Queen's Medical Research InstituteUniversity of EdinburghUniversity of PittsburghUniversity of PaduaZuyderland Medisch CentrumUniversity of ChicagoDeutsches Diabetes-Zentrum e.V.German Center for Diabetes ResearchHeinrich Heine University DüsseldorfVA Eastern Colorado Health Care SystemSlovak Academy of SciencesInstitute of Experimental Endocrinology of the Slovak Academy of SciencesUniversity of BergenHaukeland University HospitalEastern HealthMonash UniversityUniversity of ManitobaInsermSorbonne UniversitéNutrition et obésité : approches systémiquesAssistance Publique – Hôpitaux de ParisDalian Medical UniversitySecond Affiliated Hospital of Chongqing Medical UniversityChongqing Medical UniversityKing's College LondonUniversity of the WitwatersrandUniversity of Colorado AnschutzRiley Hospital for ChildrenRichard L. Roudebush VA Medical CenterInstitut d'Investigació Biomèdica de GironaHospital Universitari de Girona Doctor Josep TruetaNorthwell HealthFeinstein Institute for Medical ResearchUniversity of California, San FranciscoCedars-Sinai Medical CenterThe University of AdelaideUniversity of South DakotaSanford Children's Specialty ClinicColorado School of Public HealthRoyal Devon & Exeter NHS Foundation TrustUniversity of OxfordOxford Centre for Diabetes, Endocrinology and MetabolismChildren's Hospital of PittsburghBenaroya Research InstituteNorthwestern UniversityPopulation Health Research InstituteMcMaster UniversityUniversity of KwaZulu-NatalUniversity of VirginiaUniversity of MinnesotaUniversity of GlasgowUniversity of Southern DenmarkRigshospitaletNational Health Research InstitutesTaipei Veterans General HospitalTaichung Veterans General HospitalSteno Diabetes CentersAarhus University HospitalUniversity Children's Hospital TübingenInstitute of Diabetes ResearchNewcastle UniversityUniversity Medical Center GroningenHôpital Saint-AntoineThe Royal Melbourne HospitalThe University of MelbourneDeakin UniversityWalter and Eliza Hall Institute of Medical ResearchGuy's and St Thomas' NHS Foundation TrustHôpital Necker-Enfants MaladesInstitut CochinUniversity of Maryland, BaltimoreDartmouth CollegeAzienda USL di BolognaUniversity of BolognaPitié-Salpêtrière HospitalNational University of SingaporeKaiser PermanenteNational Institutes of HealthNational Institute of Diabetes and Digestive and Kidney DiseasesLurie Children's HospitalImpactAmerican Diabetes AssociationUniversity of AntwerpUniversity of GondarTrinity College DublinWexford General HospitalEndeavor HealthAarhus UniversitySanford ResearchUniversité de SherbrookeHarvard Pilgrim Health CareSeoul National University HospitalIcahn School of Medicine at Mount SinaiImperial College Healthcare NHS TrustImperial College LondonDr. Mohan's Diabetes Specialities CentreUniversity of AucklandCounties Manukau District Health BoardAuckland District Health BoardWellcome/MRC Institute of Metabolic ScienceOxford BioMedica (United Kingdom)University of MichiganPennington Biomedical Research CenterInstitute of Genetics and CancerThe University of SydneyRoyal Prince Alfred HospitalKaiser Permanente Center for Health ResearchDüsseldorf University Hospital

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Diabetes Management and ResearchPancreatic function and diabetesDiabetes and associated disorders

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.